Zevaquenabant

DB21590ExperimentalSmall molecule

Zevaquenabant is a small molecule drug. The usage of the INN stem '-nabant' in the name indicates that Zevaquenabant is a cannabinoid receptor antagonist. Zevaquenabant has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Nitric oxide synthase, inducible and Cannabinoid receptor 1
Curator reviewed
Formula / weight: C₂₅H₂₁ClF₃N₅O₂S · 547.98 g/mol (avg)

Resolves to

Compound

UNIIT7JYL5VB4HCAS1998760-00-1

Structure

InChIKeyNLXIJZHFEOSWPU-JOCHJYFZSA-NSMILES[H][C@@]1(CN(N=C1C1=CC=C(Cl)C=C1)C(\NC(C)=N)=N\S(=O)(=O)C1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1

Targets

P35228NOS2P21554CNR1

What you can answer from here — as of August 31, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zevaquenabant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account